Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

Suppression of the Raf/MEK/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of angiopoietin-like protein 4.

Yang YH, Wang Y, Lam KS, Yau MH, Cheng KK, Zhang J, Zhu W, Wu D, Xu A.

Arterioscler Thromb Vasc Biol. 2008 May;28(5):835-40. doi: 10.1161/ATVBAHA.107.157776. Epub 2008 Mar 13.

PMID:
18340008
[PubMed - indexed for MEDLINE]
Free Article
2.

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Roberts PJ, Der CJ.

Oncogene. 2007 May 14;26(22):3291-310. Review.

PMID:
17496923
[PubMed - indexed for MEDLINE]
3.

RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade.

Pleschka S.

Biol Chem. 2008 Oct;389(10):1273-82. doi: 10.1515/BC.2008.145. Review.

PMID:
18713014
[PubMed - indexed for MEDLINE]
4.

Partner exchange: protein-protein interactions in the Raf pathway.

Wimmer R, Baccarini M.

Trends Biochem Sci. 2010 Dec;35(12):660-8. doi: 10.1016/j.tibs.2010.06.001. Review.

PMID:
20621483
[PubMed - indexed for MEDLINE]
5.

Angiopoietins and angiopoietin-like proteins in angiogenesis.

Morisada T, Kubota Y, Urano T, Suda T, Oike Y.

Endothelium. 2006 Mar-Apr;13(2):71-9. Review.

PMID:
16728326
[PubMed - indexed for MEDLINE]
6.

ERK and beyond: insights from B-Raf and Raf-1 conditional knockouts.

Galabova-Kovacs G, Kolbus A, Matzen D, Meissl K, Piazzolla D, Rubiolo C, Steinitz K, Baccarini M.

Cell Cycle. 2006 Jul;5(14):1514-8. Epub 2006 Jul 17. Review.

PMID:
16861903
[PubMed - indexed for MEDLINE]
Free Article
7.

Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis.

Oike Y, Yasunaga K, Suda T.

Int J Hematol. 2004 Jul;80(1):21-8. Review.

PMID:
15293564
[PubMed - indexed for MEDLINE]
8.

The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions.

Yoon S, Seger R.

Growth Factors. 2006 Mar;24(1):21-44. Review.

PMID:
16393692
[PubMed - indexed for MEDLINE]
9.

Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein.

Trakul N, Rosner MR.

Cell Res. 2005 Jan;15(1):19-23. Review.

PMID:
15686621
[PubMed - indexed for MEDLINE]
Free Article
10.

The role of angiopoietin-like proteins in angiogenesis and metabolism.

Hato T, Tabata M, Oike Y.

Trends Cardiovasc Med. 2008 Jan;18(1):6-14. doi: 10.1016/j.tcm.2007.10.003. Review.

PMID:
18206803
[PubMed - indexed for MEDLINE]
11.

Targeting Raf/MEK/ERK pathway in pituitary adenomas.

Suojun Z, Feng W, Dongsheng G, Ting L.

Eur J Cancer. 2012 Feb;48(3):389-95. doi: 10.1016/j.ejca.2011.11.002. Epub 2011 Nov 24. Review.

PMID:
22119203
[PubMed - indexed for MEDLINE]
12.

Protein phosphatase 5 as a negative key regulator of Raf-1 activation.

Shah BH, Catt KJ.

Trends Endocrinol Metab. 2006 Dec;17(10):382-4. Epub 2006 Nov 3. Review.

PMID:
17084641
[PubMed - indexed for MEDLINE]
13.

Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling.

Lorenz K, Schmitt JP, Vidal M, Lohse MJ.

Int J Biochem Cell Biol. 2009 Dec;41(12):2351-5. doi: 10.1016/j.biocel.2009.08.002. Epub 2009 Aug 8. Review.

PMID:
19666137
[PubMed - indexed for MEDLINE]
14.

The integration of signaling by multiprotein complexes containing Raf kinases.

Kyriakis JM.

Biochim Biophys Acta. 2007 Aug;1773(8):1238-47. Epub 2006 Nov 7. Review.

PMID:
17276528
[PubMed - indexed for MEDLINE]
Free Article
15.

Signaling through Raf-1 in the neovasculature and target validation by nanoparticles.

Wary KK.

Mol Cancer. 2003 Jul 30;2:27. Review.

PMID:
12952546
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

BuCy RAFs drive cells into MEK addiction.

Rapp UR, Götz R, Albert S.

Cancer Cell. 2006 Jan;9(1):9-12. Review.

PMID:
16413467
[PubMed - indexed for MEDLINE]
Free Article
17.

Non-receptor protein-tyrosine kinases as molecular targets for antiangiogenic therapy (Review).

Kanda S, Miyata Y, Kanetake H, Smithgall TE.

Int J Mol Med. 2007 Jul;20(1):113-21. Review.

PMID:
17549397
[PubMed - indexed for MEDLINE]
18.

KSR and CNK: two scaffolds regulating RAS-mediated RAF activation.

Clapéron A, Therrien M.

Oncogene. 2007 May 14;26(22):3143-58. Review.

PMID:
17496912
[PubMed - indexed for MEDLINE]
19.

Targeting the ERK signaling pathway in cancer therapy.

Kohno M, Pouyssegur J.

Ann Med. 2006;38(3):200-11. Review.

PMID:
16720434
[PubMed - indexed for MEDLINE]
20.

Signaling through RAS-RAF-MEK-ERK: from basics to bedside.

Zebisch A, Czernilofsky AP, Keri G, Smigelskaite J, Sill H, Troppmair J.

Curr Med Chem. 2007;14(5):601-23. Review.

PMID:
17346150
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk